__timestamp | Galapagos NV | Lantheus Holdings, Inc. |
---|---|---|
Wednesday, January 1, 2014 | 9079000 | 72429000 |
Thursday, January 1, 2015 | 20309000 | 78634000 |
Friday, January 1, 2016 | 16945000 | 75374000 |
Sunday, January 1, 2017 | 20559000 | 92157000 |
Monday, January 1, 2018 | 29641000 | 93326000 |
Tuesday, January 1, 2019 | 88258000 | 103132000 |
Wednesday, January 1, 2020 | 162170000 | 110171000 |
Friday, January 1, 2021 | 167218000 | 218817000 |
Saturday, January 1, 2022 | 239528000 | 233827000 |
Sunday, January 1, 2023 | 94252000 | 267194000 |
Infusing magic into the data realm
In the ever-evolving landscape of corporate finance, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. This analysis delves into the SG&A expenses of Lantheus Holdings, Inc. and Galapagos NV from 2014 to 2023.
Lantheus Holdings, Inc. has demonstrated a consistent upward trend in SG&A expenses, peaking in 2023 with a 270% increase from 2014. This reflects their strategic investments in operational growth and market expansion. In contrast, Galapagos NV experienced a more volatile trajectory, with a significant spike in 2022, marking a 2,500% increase from 2014, before a notable decline in 2023.
These trends highlight the differing strategic approaches of the two companies. Lantheus's steady increase suggests a focus on sustainable growth, while Galapagos's fluctuations may indicate adaptive strategies in response to market dynamics. Understanding these patterns provides valuable insights into each company's financial health and strategic priorities.
Comparing SG&A Expenses: Gilead Sciences, Inc. vs Galapagos NV Trends and Insights
Bio-Techne Corporation vs Galapagos NV: SG&A Expense Trends
Walgreens Boots Alliance, Inc. or Galapagos NV: Who Manages SG&A Costs Better?
Ascendis Pharma A/S and Lantheus Holdings, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Galapagos NV
Comparing SG&A Expenses: Halozyme Therapeutics, Inc. vs Lantheus Holdings, Inc. Trends and Insights
Selling, General, and Administrative Costs: Lantheus Holdings, Inc. vs ImmunityBio, Inc.
Comparing Cost of Revenue Efficiency: Lantheus Holdings, Inc. vs Galapagos NV
Lantheus Holdings, Inc. and Novavax, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV
Who Optimizes SG&A Costs Better? Merus N.V. or Galapagos NV
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights